Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qure.ai is a private healthcare AI company focused on AI-powered medical imaging and workflow products for earlier detection and management of high-burden diseases. Its commercial portfolio includes chest X-ray, head CT, lung nodule management, and care coordination products used by hospitals, health systems, public health programs, and life sciences partners. The company is particularly active in lung cancer, tuberculosis, stroke, and emergency radiology, and has built a globally deployed software platform with multiple FDA-cleared indications. Qure.ai also collaborates with pharmaceutical and medtech companies to support screening, triage, and patient pathway optimization. The business is best characterized as a commercial-stage digital health and medical imaging AI company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qure.ai.